Trial Profile
A Study on the Efficacy, Pharmacokinetics and Adverse Effects of Paliperidone ER
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics; Pharmacogenomic
- 20 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 07 May 2015 New trial record